TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results April 11, 1997
TCL Archive Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned March 17, 1995